Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nobuhiro Tsuchiya, Toshiaki Yoshikawa, Norihiro Fujinami, Keigo Saito, Shoichi Mizuno, Yu Sawada, Itaru Endo & Tetsuya Nakatsura. (2017) Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma. OncoImmunology 6:10.
Read now
Read now
Yu Sawada, Toshiaki Yoshikawa, Kazuya Ofuji, Mayuko Yoshimura, Nobuhiro Tsuchiya, Mari Takahashi, Daisuke Nobuoka, Naoto Gotohda, Shinichiro Takahashi, Yuichiro Kato, Masaru Konishi, Taira Kinoshita, Masafumi Ikeda, Kohei Nakachi, Naoya Yamazaki, Shoichi Mizuno, Tadatoshi Takayama, Kenji Yamao, Katsuhiko Uesaka, Junji Furuse, Itaru Endo & Tetsuya Nakatsura. (2016) Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients. OncoImmunology 5:5.
Read now
Read now
Mohammad A. Sayem, Yusuke Tomita, Akira Yuno, Masatoshi Hirayama, Atsushi Irie, Hirotake Tsukamoto, Satoru Senju, Eiji Yuba, Toshiaki Yoshikawa, Kenji Kono, Tetsuya Nakatsura & Yasuharu Nishimura. (2016) Identification of glypican-3-derived long peptides activating both CD8+ and CD4+ T cells; prolonged overall survival in cancer patients with Th cell response. OncoImmunology 5:1.
Read now
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:12.
Read now
Read now
Articles from other publishers (24)
Xiufeng Zheng, Xun Liu, Yanna Lei, Gang Wang & Ming Liu. (2022) Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Masatake Taniguchi, Shoichi Mizuno, Toshiaki Yoshikawa, Norihiro Fujinami, Motokazu Sugimoto, Shin Kobayashi, Shinichiro Takahashi, Masaru Konishi, Naoto Gotohda & Tetsuya Nakatsura. (2020) Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosis. Cancer Science 111:8, pages 2747-2759.
Crossref
Crossref
Bonala Sabeerabi, Venkat R. Arva Tatireddygari & Ramakrishna Vadde. 2020. Immunotherapy for Gastrointestinal Malignancies. Immunotherapy for Gastrointestinal Malignancies
113
158
.
Yaodong Zhang, Zhengshan Wu, Ke Wang, Sheng Han, Changxian Li & Xiangcheng Li. (2019) Long-term survival after anterior approach right hepatectomy combined with inferior vena cava thrombectomy using trans-diaphragmatic intrapericardial inferior vena cava occlusion: a case report and review of the literature. BMC Surgery 19:1.
Crossref
Crossref
Wei Tse Li, Angela E. Zou, Christine O. Honda, Hao Zheng, Xiao Qi Wang, Tatiana Kisseleva, Eric Y. Chang & Weg M. Ongkeko. (2019) Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy. Cancers 11:9, pages 1273.
Crossref
Crossref
Yasuhiro Shimizu, Toshihiro Suzuki, Toshiaki Yoshikawa, Itaru Endo & Tetsuya Nakatsura. (2019) Next-Generation Cancer Immunotherapy Targeting Glypican-3. Frontiers in Oncology 9.
Crossref
Crossref
Yu Akazawa, Toshihiro Suzuki, Toshiaki Yoshikawa, Shoichi Mizuno, Yasunari Nakamoto & Tetsuya Nakatsura. (2019) Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma. World Journal of Meta-Analysis 7:3, pages 80-95.
Crossref
Crossref
Shoichi Hazama, Koji Tamada, Yoshiyuki Yamaguchi, Yutaka Kawakami & Hiroaki Nagano. (2018) Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy. Annals of Gastroenterological Surgery 2:4, pages 289-303.
Crossref
Crossref
Yasuhiro Shimizu, Toshihiro Suzuki, Toshiaki Yoshikawa, Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo & Tetsuya Nakatsura. (2018) Cancer immunotherapy-targeted glypican-3 or neoantigens. Cancer Science 109:3, pages 531-541.
Crossref
Crossref
Fubo Zhou, Wenting Shang, Xiaoling Yu & Jie Tian. (2018) Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment. Medicinal Research Reviews 38:2, pages 741-767.
Crossref
Crossref
Vikrant Rai, Joe Abdo, Abdullah N. Alsuwaidan, Swati Agrawal, Poonam Sharma & Devendra K. Agrawal. (2017) Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma. Molecular and Cellular Biochemistry 437:1-2, pages 13-36.
Crossref
Crossref
Yi-Fan Zhang, Jessica Hong & Mitchell Ho. 2017. Immunotherapy of Hepatocellular Carcinoma. Immunotherapy of Hepatocellular Carcinoma
103
119
.
Arthur ZimmermannArthur Zimmermann. 2017. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
65
90
.
Yuta Yoshizaki, Eiji Yuba, Toshihiro Komatsu, Keiko Udaka, Atsushi Harada & Kenji Kono. (2016) Improvement of Peptide-Based Tumor Immunotherapy Using pH-Sensitive Fusogenic Polymer-Modified Liposomes. Molecules 21:10, pages 1284.
Crossref
Crossref
Norihiro Fujinami, Toshiaki Yoshikawa, Yu Sawada, Manami Shimomura, Tatsuaki Iwama, Shiori Sugai, Shigehisa Kitano, Yasushi Uemura & Tetsuya Nakatsura. (2016) Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model. Biochemistry and Biophysics Reports 5, pages 482-491.
Crossref
Crossref
Tetsuya NAKATSURA. (2016) Era of cancer immunotherapy has come. Japanese Journal of Clinical Immunology 39:3, pages 164-171.
Crossref
Crossref
Arthur ZimmermannArthur Zimmermann. 2016. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
1
27
.
Xin Luo, Binhao Zhang, Shuilin Dong, Bixiang Zhang & Xiaoping Chen. (2015) Hepatocellular Carcinoma With Tumor Thrombus Occupying the Right Atrium and Portal Vein. Medicine 94:34, pages e1049.
Crossref
Crossref
YULIANG WANG, YINLONG WANG, HONG MU, TAO LIU, XIAOBO CHEN & ZHONGYANG SHEN. (2015) Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells. Molecular Medicine Reports 11:5, pages 3361-3367.
Crossref
Crossref
Maria Tretiakova, Debra L. Zynger, Chunyan Luan, Nicole K. Andeen, Laura S. Finn, Masha Kocherginsky, Bin T. Teh & Ximing J. Yang. (2014) Glypican 3 overexpression in primary and metastatic Wilms tumors. Virchows Archiv 466:1, pages 67-76.
Crossref
Crossref
Toshiaki Yoshikawa, Yu Sawada, Mayuko Yoshimura, Kazuya Ofuji & Tetsuya Nakatsura. 2015. Inflammation and Immunity in Cancer. Inflammation and Immunity in Cancer
133
143
.
Scott J. Gilbert & Seth Wright. 2015. Onconephrology. Onconephrology
163
181
.
Tim F. Greten, Austin G. Duffy & Firouzeh Korangy. (2013) Hepatocellular Carcinoma from an Immunologic Perspective. Clinical Cancer Research 19:24, pages 6678-6685.
Crossref
Crossref
YOSHITAKA TADA, TOSHIAKI YOSHIKAWA, MANAMI SHIMOMURA, YU SAWADA, MAYUKO SAKAI, HIROFUMI SHIRAKAWA, DAISUKE NOBUOKA & TETSUYA NAKATSURA. (2013) Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican-3-derived peptide. International Journal of Oncology 43:4, pages 1019-1026.
Crossref
Crossref